(Q44442604)

English

A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease

scientific article published in February 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

author name string

Richard S Castaldo

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Bartolome R Celli

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Fernando Gomez

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Nicole LaVallee

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Joseph Souhrada

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

John P Hanrahan

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

542-557

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The costs of treating COPD in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Toward a consensus definition for COPD exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The chronic obstructive pulmonary disease exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious etiology of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Do bacteria cause exacerbations of COPD?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of infection in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of bacteria in exacerbations of COPD. A constructive view

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of guidelines and risk stratification in acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of macrolides and ketolides: focus on respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory effects of macrolides in lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The biology of bacterial colonization and invasion of the respiratory mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980095-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80095-4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44442604&oldid=2079451949"